flag flag  

Seven-year follow-up of infliximab therapy in rheumatoid arthritis patients with severe long-standing refractory disease: attrition rate and evolution of disease activity

Description : Introduction: This study is based on the results from a Belgian expanded access program in which patients with active refractory and erosive rheumatoid arthritis (RA) were treated with intravenous infusions of infliximab in combination with methotrexate. The objectives of this study were to evaluate...
Language(s) : English
Subject(s) : Treatment Outcome , Severity of Illness Index , Middle Aged , Methotrexate , Male , Longitudinal Studies , Kaplan-Meier Estimate , Infusions, Intravenous , Humans , Health Surveys , Follow-Up Studies , Female , Drug Therapy, Combination , Disease Progression , Belgium , Arthritis, Rheumatoid , Antirheumatic Agents , Antibodies, Monoclonal
Publisher(s) : London Biomed Central Ltd
Contributor(s) : UCL - Cliniques universitaires Saint-Luc , UCL - SSS/IREC - Institut de recherche expérimentale et clinique
Source(s) :
Publication Date(s) : 2010-01-01